3D printing: The future of pharmaceuticals

By DFE Pharma

Despite still being a small segment of pharmaceutical manufacturing, 3D printing is becoming a reality, with one drug approved by the FDA already on the market produced with this technology. In the case of 3D powder bed tablet printing, the powder’s properties are critical, which aligns with DFE Pharma’s core expertise: mechanistic understanding of powder behaviour.

Enter your details below to view the free white paper

By downloading this White Paper, you acknowledge that may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how Business Trade Media International Limited may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.